Cristina B. Brinkmann
Fujifilm Diosynth Biotechnologies
Drug Product & Finished Goods Business Steering Group Lead
Cristy assumed the role of Business Steering Group Lead for drug product and finished goods for FUJIFILM Diosynth Biotechnologies in 2021. In this capacity, she helps guide and strategize the overall drug product and finished goods service offering to meet the evolving market demands.
Cristy began her career with FUJIFILM Diosynth Biotechnologies in 2012 at the Research Triangle Park, NC site when she joined the process development team, later transitioning into program management.
Prior to joining FUJIFILM Diosynth Biotechnologies, she worked for four years in academia at Scripps Research Institute of San Diego. She then transitioned into the private sector in the R&D of Peregrine Pharmaceuticals in California and then to Xencor, until her move to North Carolina.
Cristina earned her BS in Biology from University of California, Riverside in Biology.
Cristy began her career with FUJIFILM Diosynth Biotechnologies in 2012 at the Research Triangle Park, NC site when she joined the process development team, later transitioning into program management.
Prior to joining FUJIFILM Diosynth Biotechnologies, she worked for four years in academia at Scripps Research Institute of San Diego. She then transitioned into the private sector in the R&D of Peregrine Pharmaceuticals in California and then to Xencor, until her move to North Carolina.
Cristina earned her BS in Biology from University of California, Riverside in Biology.